MPM BioImpact LLC
Annual return '25
+35.4%
SPY '25
+17.7%
Alpha
+17.7ptsvs SPY
Invested
$1.3B
Holdings
41
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 94%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$DBVT
DBV Technologies S A
Held since at least Q1 2024
8.4%
02
$CGEM
Cullinan Therapeutics, Inc.
Held since at least Q1 2024
8.4%
03
$AKTS
Aktis Oncology, Inc.
Held since at least Q1 2024
6.7%
04
$LQDA
Liquidia Corporation
Held since at least Q1 2024
4.1%
05
$ALMS
Alumis Inc
Held since at least Q1 2024
4.1%
06
$EWTX
Edgewise Therapeutics Inc
Held since at least Q1 2024
4.0%
07
$RVMD
Revolution Medicines, Inc.
Held since at least Q1 2024
3.8%
08
$AGIO
Agios Pharmaceuticals Inc
Held since at least Q1 2024
3.4%
09
$CORT
Corcept Therapeutics, Inc.
Held since at least Q1 2024
3.1%
10
$TRVI
Trevi Therapeutics Inc
Held since at least Q1 2024
3.0%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:28 UTC.